机构地区:[1]江西中医学院现代中药制剂教育部重点实验室,江西南昌330004 [2]成都中医药大学药学院,四川成都610075
出 处:《中国新药与临床杂志》2015年第5期351-356,共6页Chinese Journal of New Drugs and Clinical Remedies
基 金:国家自然科学基金资助项目(81060347);国家留学基金委资助项目(留金法[2012]5031);江西省青年科学学培养计划项目(20122BCB23021);江西省教育厅科学技术研究项目(GJJ13606)
摘 要:目的建立液相色谱-串联质谱法(LC-MS/MS)同时测定非那西丁(PN)、咪达唑仑(MDZ)在大鼠血液中的含量。方法大鼠随机被分为PN组、MDZ组和PN-MDZ合用组(均n=6),分别尾静脉注射PN、MDZ及PN和MDZ混合探针药物,剂量均为1 mg·kg-1。于指定时间眼眶采集血样,以苯海拉明为内标,采用LC-MS/MS测定大鼠血浆中探针药物及其代谢产物的浓度。色谱柱为Kinetex XB-C18柱(100 mm×3.0 mm,2.6μm),流动相为甲醇∶0.025%甲酸水,进行梯度洗脱。电喷雾离子源,以多反应离子监测方法进行正离子扫描,PN和其代谢产物醋氨酚(Ace),MDZ和其代谢产物1-羟基咪达唑仑(1-OH-MDZ)及苯海拉明离子对分别为m/z 180.2→110.0,m/z 152.2→110.1,m/z 326.2→291.2,m/z 342.2→324.2和m/z 256.3→167.2。结果PN、Ace、MDZ和1-OH-MDZ线性范围分别为:4.288~21 440 ng·m L-1、1.038~5 190 ng·m L-1、4.664~11 660 ng·m L-1、0.01~50 ng·m L-1;回收率、稳定性和日内、日间精密度均符合生物样品分析要求;PN和MDZ单用与合用前后药动学参数无显著差异(P〉0.05)。PN单用和与MDZ合用后t1/2分别为(0.44±0.15)、(0.42±0.08)h,ρmax分别为(9.35±1.58)、(10.17±0.76)μg·m L-1,AUC0-6 h分别为(4.21±0.63)、(4.90±0.42)μg·h·m L-1;MDZ单用和与PN合用后t1/2分别为(0.64±0.09)、(0.68±0.05)h,ρmax分别为(3.48±0.51)、(3.01±0.64)μg·m L-1,AUC0-6 h分别为(2.58±0.41)、(2.08±0.29)μg·h·m L-1。结论建立的测定方法可用于PN、MDZ以及其代谢产物的药动学研究,并证明PN、MDZ在大鼠体内基本没有代谢的相互作用。AIM To establish a LC-MS/MS method for the simultaneous determination of phenacetin( PN) and midazolam( MDZ) in rat plasma. METHODS Rats were divided into PN, MDZ, PN and MDZ combination groups( n = 6 in each). Blood samples were collected from the eyes at specified times after phenacetin( 1 mg·kg-1), midazolam( 1 mg·kg-1) and phenacetin( 1 mg·kg-1) + midazolam( 1 mg·kg-1)mixed probe drug solutions were given to rats individually by intravenous injection. The plasma concentration of PN, MDZ and their metabolites were detected by LC-MS/MS, in which diphenhydramine was used as the internal standard(IS). The analytes were separated using a Kinetex XB-C18(100 mm × 3.0 mm, 2.6 μm).The mobile phase consisted of methanol-0.025% formic acid water solution with a gradient elution. Electrospray ionization source was applied, the protonated ion of the analytes was detected in positive ionization by multiple reaction monitoring mode. The mass transition pairs of m/z 180.2 →110.0 for PN, m/z 152.2 →110.1 for acetaminophen, m/z 326.2→291.2 for MDA, m/z 342.2→324.2 for 1-hydroxymidazolam and m/z 256.3→167.2for IS. RESULTS The linear calibration curve of PN, acetaminophen, MDZ and 1-hydroxymidazolam were obtained in the concentration range of 4.288-21 440 ng·m L-1, 1.038-5 190 ng·m L-1, 4.664-11 660 ng·m L-1and 0.01-50 ng·m L-1respectively. Recoveries, stabilities, the intra-day and inter-day precisions were all met the requirements of biological samples analysis. The pharmacokinetic parameters of PN and MDZ had no significant change after combination administration(P 〉 0.05). The t1/2of PN administrated alone and combined with MDZ were(0.44 ± 0.15) and(0.42 ± 0.08) h, ρmaxwere(9.35 ± 1.58) and(10.17 ± 0.76) μg·m L-1,AUC0-6 hwere(4.21 ± 0.63) and(4.90 ± 0.42) μg·h·m L-1. The t1/2of MDZ administrated alone and combined with PN were( 0.64 ± 0.09) and( 0.68 ± 0.05) h, ρmaxwere( 3.48 ± 0.51) and( 3.01 ± 0.64) μg�
关 键 词:咪达唑仑 非那西丁 色谱法 高压液相 串联质谱法
分 类 号:R917[医药卫生—药物分析学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...